Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer
Authors Suo N, Wang M, Jin Y, Ding J, Gao X, Sun X, Zhang H, Cui M, Zheng J, Li N, Jin X, Jiang S
Received 4 October 2018
Accepted for publication 4 January 2019
Published 15 February 2019 Volume 2019:14 Pages 1241—1254
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Justinn Cochran
Peer reviewer comments 2
Editor who approved publication: Dr Mian Wang
Ning Suo,1 Muwen Wang,1 Yang Jin,1 Jun Ding,2 Xueping Gao,3 Xiaoliang Sun,1 Haiyang Zhang,1 Meng Cui,4 Jilu Zheng,1 Nianlu Li,5 Xunbo Jin,1,* Shaobo Jiang1,*
1Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China; 2Department of Mechanical Engineering, University of Maryland, Baltimore County, Baltimore, MD, 21250, USA; 3School of Material Science and Engineering, Shandong University, Jinan 250100, China; 4Department of Urology, Shandong Provincial Maternity and Childcare Hospital, Jinan 250014, China; 5School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, China
*These authors contributed equally to this work
Background: Traditional intravesical instillation treatment in bladder cancer has limited efficacy, which results in a high frequency of recurrence.
Purpose: The aim of this study was to report on an epirubicin (EPI)-loaded magnetic multiwalled carbon nanotube (mMWCNTs-EPI) system for intravesical instillation in place of the current formulation.
Methods: The mMWCNTs-EPI system was formulated with carboxylated MWCNTs, Fe3O4 magnetic nanoparticles, and EPI. Features and antitumor activity of the system were investigated.
Results: Under the effect of external magnets, the mMWCNTs-EPI system showed sustained release and prolonged retention behavior and better antitumor activity than free EPI. The mMWCNTs-EPI system had higher efficiency in enhancing cytotoxicity and inhibiting proliferation in vitro and in vivo than free EPI. Our studies also revealed the atoxic nature of mMWCNTs.
Conclusion: These findings suggested that mMWCNTs are effective intravesical instillation agents with great potential for clinical application.
Keywords: carbon nanotubes, intravesical instillation, epirubicin, intravesical drug delivery
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]